Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS) [clinicaltrials_resource:2ccab4c9ff5ce9c3578c0b59312b0cfc]
Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS) [clinicaltrials:NCT00294164]An Efficacy and Safety Trial of Serostim® in the Maintenance of the Treatment Effect Obtained During the Study of Serostim® in Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome [clinicaltrials:NCT00294918]
condition [clinicaltrials_vocabulary:condition]
Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS) [clinicaltrials_resource:2ccab4c9ff5ce9c3578c0b59312b0cfc]
Bio2RDF identifier
2ccab4c9ff5ce9c3578c0b59312b0cfc
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2ccab4c9ff5ce9c3578c0b59312b0cfc
identifier
clinicaltrials_resource:2ccab4c9ff5ce9c3578c0b59312b0cfc
title
Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)
@en
label
Human Immunodeficiency Virus-a ...... ab4c9ff5ce9c3578c0b59312b0cfc]
@en